daprodustat

GSK’s daprodustat obtains positive opinion from EMA CHMP
Pharmaceutical Business Review
Tue, 06/27/23 - 10:12 am
EMA
Europe
GSK
CHMP
daprodustat
chronic kidney disease
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections
Fierce Pharma
Thu, 02/2/23 - 10:28 am
GSK
FDA
daprodustat
Jesduvroq
anemia
chronic kidney disease
GSK’s “crown jewels” already look tarnished
EP Vantage
Wed, 11/23/22 - 07:27 am
GSK
Blenrep
Emma Walmsley
daprodustat
gepotidacin
otilimab
Jemperli
Zejula
cabotegravir
As GSK gears up for high-stakes daprodustat panel review, FDA flags some safety concerns
Fierce Pharma
Wed, 10/26/22 - 10:26 am
GSK
anemia
daprodustat
FDA
GSK goes for gold as FDA starts review of daprodustat
Pharmaforum
Tue, 04/19/22 - 10:47 am
GSK
chronic kidney disease
anemia
daprodustat
FDA
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival
Pharmaforum
Mon, 06/29/20 - 06:21 pm
GSK
anemia
chronic kidney disease
daprodustat
Japan
Astellas
Kyowa Kirin
GSK’s CEO Walmsley aiming for six new approvals in 2020
Pharmaforum
Tue, 01/14/20 - 10:07 am
GSK
Pharma CEOs
Emma Walmsley
JPMHC 2020
Zejula
Trelegy
daprodustat
belantamab mafodotin
Chasing Astellas and Mitsubishi, GSK files for Japanese approval of oral anemia drug
Fierce Biotech
Wed, 08/21/19 - 09:33 am
GSK
Japan
renal anemia
daprodustat
GlaxoSmithKline Launches Anemia Drug Trial
Investopedia
Sun, 11/27/16 - 03:55 pm
GSK
clinical trials
daprodustat
anemia
kidney disease